Why do Pharmaceuticals companies need SOC 2 Certification?

Pharmaceuticals firms — Pharmaceuticals, MSPs, cloud and software vendors — host customer data in multi-tenant environments. A SOC 2 report is the AICPA-recognised proof that you operate controls against the Trust Services Criteria, and is the default qualification in most North American enterprise vendor security reviews.

Can SOC 2 be combined with ISO 27001 for Pharmaceuticals companies?

Yes — and most of our Pharmaceuticals clients run both. SOC 2 and ISO 27001 share roughly 70-80% of controls, so running them in parallel typically saves 35-40% of cost and time versus sequential audits.

How much does SOC 2 Certification for Pharmaceuticals cost?

Total cost depends on scope, TSC selected, headcount and CPA audit fees. We publish a fixed-fee written quote within 48 hours of a readiness call. Most Pharmaceuticals clients fall in the USD 5,000-30,000 range for advisory, plus the CPA firms direct attestation invoice.

Who issues the SOC 2 report?

A licensed CPA firm issues the SOC 2 attestation report — not ISpectra. We prepare your environment, run a free VAPT and a full internal audit, then coordinate the independent CPA audit so you pass first time.

Does SOC 2 cover cloud workloads on AWS, Azure and GCP?

Yes. Trust Services Criteria are platform-agnostic. We translate every relevant criterion into AWS, Azure and GCP configurations — IAM, KMS, GuardDuty, Defender, VPC, logging, CSPM and vulnerability management — with automated evidence.

Pharmaceuticals Industry · SOC 2 Type I & Type II · AICPA TSC

SOC 2 Certification for Pharmaceuticals
— Type I in 2 Months, Type II in 4

A SOC 2 consulting partner built for Drug discovery & R&D, Clinical trials & CRO and Manufacturing & GxP. We get you SOC 2 Certification for Pharmaceuticals end-to-end — from readiness assessment to a clean CPA-attested Type I and Type II report.

As certified partners of Drata, Sprinto and Secureframe, we operationalise every Trust Services Criterion inside the tools engineering already runs — AWS, Azure, GCP, GitHub, Okta and Jira — so evidence is collected automatically across the observation window.

0

Months to SOC 2 Type I

0

Global Enterprises Served

0

First-attempt audit pass rate

0

Drata . Sprinto . Secureframe partner

Get Your Free SOC 2 Roadmap See the 6-Stage Process

Free Roadmap

24h Response

Request a Free Pharmaceuticals SOC 2 Readiness Roadmap

4.9/5 200+ Pharmaceuticals clients 100% first pass

SSL Encrypted No spam ever 100% Confidential

Why It Matters For Pharmaceuticals

Why Pharmaceuticals Companies Can No Longer Skip SOC 2

Pharma firms hold research IP, clinical-trial data and patient information of immense value. Sponsors, CROs and enterprise partners require a SOC 2 report before they share regulated data and systems. Without it, research collaborations and data agreements stall.

SOC 2 Certification for Pharmaceuticals is the AICPA-recognised attestation that an independent CPA firm has examined your controls against the five Trust Services Criteria — Security, Availability, Processing Integrity, Confidentiality and Privacy. A Type I report proves your controls are well-designed; a Type II report proves they actually operated effectively across an observation window of about 4 months. To an enterprise buyer, that report is the difference between “approved vendor” and “rejected”.

We map criteria to regulated R&D and manufacturing — research-IP protection, GxP and 21 CFR Part 11 system access, clinical-data integrity, and partner oversight. SOC 2 evidence complements your validated environment so sponsors and CROs can share data confidently.

What your Pharmaceuticals business walks away with

✓A CPA-attested SOC 2 Type I & Type II report — the document every enterprise procurement team asks for
✓A complete control environment: risk register, 30+ policies and a control library mapped to the Trust Services Criteria
✓Automated evidence collection via Drata, Sprinto or Secureframe — continuous monitoring across the observation window
✓Reusable mapping to GxP / GAMP 5, 21 CFR Part 11, HIPAA and ISO 27001 — one control set, many audits
✓A complimentary VAPT and a pre-completed Vendor Security Questionnaire (CAIQ / SIG) for every prospect
✓Independent CPA coordination managed end-to-end — not a templated checklist

The Cost Of Inaction

The Real Business Cost of Skipping SOC 2 Certification for Pharmaceuticals

For B2B Pharmaceuticals companies, no SOC 2 report is a measurable drag on revenue, sales velocity and buyer trust.

$

Lost enterprise deals

Sponsors, CROs and enterprise partners require a SOC 2 report before sharing regulated data and systems.

!

Breach exposure

Loss of research IP or trial data is irreversible and immensely costly; uncertified firms face heightened risk.

)

Slower sales cycles

Without SOC 2, research collaborations and data-sharing agreements stall.

⚠

Regulatory & insurance pressure

GxP, 21 CFR Part 11 and HIPAA increasingly expect audited security controls.

The ISpectra Method

Our 6-Stage SOC 2 Certification for Pharmaceuticals Process

Click through the timeline — or hit play and watch the sprint run. Most Pharmaceuticals clients reach SOC 2 Type I in about 2 months, then SOC 2 Type II in about 4 months.

Engineered, Not Templated

The 5 Trust Services Criteria, mapped to your Pharmaceuticals stack

How we operationalise each Trust Services Criterion — in the tools your engineers already run, with evidence captured automatically in Drata, Sprinto or Secureframe.

CC

Security · Mandatory

Access control, change management, risk assessment and continuous monitoring across your GxP systems, ELN/LIMS and clinical-data stores.

AWS IAMOkta SSO + MFA24/7 logging

A1

Availability · Optional

Uptime, resilience and tested recovery so the services delivering your research IP and clinical-trial data stay available as committed.

Multi-AZSLA monitoringTested backups / DR

PI

Processing Integrity · Optional

Complete, valid, accurate and timely processing of research IP and clinical-trial data.

Input validationJob monitoringQA gates

C

Confidentiality · Optional

Encryption, classification and least-privilege protection for research IP and clinical-trial data.

KMS / TLSData classificationTenant isolation

P

Privacy · Optional

Lawful collection, use, retention and disposal of the personal data across your GxP systems, ELN/LIMS and clinical-data stores.

Notice & consentDSAR handlingGDPR / CCPA

EV

Evidence, collected automatically

Each criterion maps to controls captured continuously — no screenshot scramble before the CPA examination.

DrataSprintoSecureframe

Sub-Verticals We Serve

Pharmaceuticals Sub-Verticals We Certify

Tailored SOC 2 Certification for Pharmaceuticals engagements designed around the data flows and buyer expectations of every Pharmaceuticals business model.

01

Drug discovery & R&D

Research platforms and labs handling proprietary IP.

02

Clinical trials & CRO

Trial-management and CRO platforms processing patient data.

03

Manufacturing & GxP

GxP, MES and quality-management systems.

04

Pharmacovigilance

Safety, adverse-event and PV data platforms.

05

Regulatory & RIM

Regulatory-information-management and submission tools.

06

Commercial & supply

Distribution, serialization and commercial platforms.

One Programme, Many Audits

Frameworks Pharmaceuticals teams run alongside SOC 2

SOC 2 reuses most of the same controls as the standards your Pharmaceuticals buyers, regulators and auditors already expect — so one control set satisfies many. We map the overlap and reuse up to 80% of your evidence.

GxP / GAMP 5

Good-practice computerised-system controls.

21 CFR Part 11

Electronic records and signatures.

HIPAA

For clinical and patient data.

ISO 27001

ISMS certification overlapping SOC 2.

GDPR

For EU trial-participant data.

SOC 2 Processing Integrity

Trial-data accuracy and completeness.

Risk, Under Control

The Pharmaceuticals security risks SOC 2 puts under control

The Trust Services Criteria map directly to the threats that matter most in Pharmaceuticals — here is what your SOC 2 programme is built to contain.

01

Research-IP theft

Loss of proprietary compounds, methods and data.

02

Clinical-data integrity failure

Tampered or incomplete trial records.

03

Pharmacovigilance exposure

Leakage of adverse-event and patient data.

04

Partner & CRO risk

Collaborator weaknesses exposing regulated data.

The Decision Matters

Without a report, or SOC 2 attested — side by side

The reality for a B2B Pharmaceuticals company, both views at a glance.

Without SOC 2

The real cost of doing nothing

×Sponsors, CROs and enterprise partners screen you out before the first call without a report
×Every Pharmaceuticals security review restarts from a blank questionnaire
×Higher exposure for research IP and clinical-trial data with no attested controls
×Tougher cyber-insurance terms & longer GxP / GAMP 5 / 21 CFR Part 11 audits
×One failed review erodes hard-won Pharmaceuticals trust

With SOC 2 — attested

The upside of getting attested

✓Clear sponsors, CROs and enterprise partners procurement the day your report is issued
✓30–45% faster Pharmaceuticals sales cycles with a pre-built CAIQ / SIG
✓Stronger cyber-insurance terms with attested controls over research IP and clinical-trial data
✓One control set reused across GxP / GAMP 5, 21 CFR Part 11 and HIPAA
✓Engineering hours returned through automated evidence

Which report?

SOC 2 Type I vs Type II

SOC 2 Type I

Point-in-time

Attests controls are suitably designed on a specific date
~2 months from kickoff
Fastest way to answer a buyer asking for SOC 2 now

SOC 2 Type II

Over a period

Attests controls operated effectively over a ~4-month window
The report most enterprise buyers ultimately require
Continuous evidence, renewed annually on a rolling basis

Illustrative ROI

What’s a stuck deal worth?

Average contract value (ACV)

$60,000

Enterprise deals blocked on “no SOC 2” per year

8

Pipeline you could unlock

$480,000

Illustrative estimate only — based on the numbers you enter.

2 Limited-Time Offers

Two ways to save on SOC 2 Certification for Pharmaceuticals

SOC 2 expects a working vulnerability-management programme, so every SOC 2 Certification for Pharmaceuticals engagement ships with a complimentary external Penetration Test and Network VAPT. And if you add any other framework (ISO 27001, ISO 27701, HIPAA, GDPR or PCI-DSS) to your Pharmaceuticals engagement, a flat 10% GRC Bundle discount kicks in across the entire programme.

FREE VAPT

Offer 1 · Active Now

Free VAPT with every SOC 2 engagement

A complimentary external Penetration Test plus Network Vulnerability Assessment, executed by our in-house CREST + OSCP certified team — bundled into every standalone SOC 2 Certification for Pharmaceuticals.

✓External & internal network VAPT

✓Pharmaceuticals web-app & API pen testing

✓OWASP Top 10 + SANS CWE-25

✓CPA-auditor-ready report

Bundle Saver

10% OFF

Offer 2 · Multi-Framework

10% off when you add 1+ certifications

Take SOC 2 together with any other framework (ISO 27001, ISO 27701, HIPAA, GDPR or PCI-DSS) and we apply a flat 10% GRC Bundle discount across the entire Pharmaceuticals engagement.

✓SOC 2 + ISO 27001

✓SOC 2 + ISO 27701

✓SOC 2 + HIPAA

✓SOC 2 + GDPR / PCI-DSS

Both offers stack. Bundle SOC 2 with any other framework and you get the 10% GRC discount plus the Free VAPT included — on top of the up-to-80% control-evidence reuse that already cuts multi-framework effort.

Why ISpectra

Why Leading Pharmaceuticals Companies Choose ISpectra for SOC 2

A specialist consultancy delivering SOC 2 Certification for Pharmaceuticals firms across the US, India, the EU and the Middle East — with a 100% first-attempt audit pass record.

2 mo

To Type I report

Fastest fixed-fee delivery in the industry — kickoff to a clean CPA-attested Type I report.

3×

Compliance automation partner

Certified partner of Drata, Sprinto and Secureframe — lower licensing and faster evidence.

100%

First-attempt audit pass

Zero failed examinations across 200+ engagements — every issue caught in our internal audit.

Get a fixed-fee, written quote for your SOC 2 programme within 48 hours of your readiness call.

Get a Fixed-Fee Quote WhatsApp Us

What Enterprise Clients Say

Real B2B Results from
Real Partnerships

“ISpectra expertly guided us through every step of the compliance process, turning complex regulatory requirements into practical, actionable steps. Their partnership-centric approach and responsiveness made all the difference. Achieving compliance with their help has significantly enhanced our credibility and trustworthiness in the market.”

IZ

Irina Zakharchenko

Chief Operations and People Officer

DocsDNA

SOC 2 Certified

FAQ — SOC 2 for Pharmaceuticals

Frequently Asked SOC 2 Questions

Everything Pharmaceuticals founders, CTOs and security leads ask before starting SOC 2.

SOC 2 is an AICPA attestation in which a licensed CPA firm examines your controls against the five Trust Services Criteria. For Pharmaceuticals, MSPs and cloud providers it is the universally accepted proof that customer data is handled securely — and is the default qualifying filter in most North American enterprise vendor reviews.

Type I attests that your controls are suitably designed at a single point in time. Type II attests that those controls operated effectively across an observation window of about 4 months. Most enterprise buyers ultimately require Type II, so we get you Type I in about 2 months then support the observation period.

Most Pharmaceuticals companies reach Type I in about 2 months with our fixed-fee model, then Type II in about 4 months after the observation window. Larger multi-product Pharmaceuticals groups running ISO 27001 in parallel may take a little longer.

Security (the Common Criteria) is mandatory. Most Pharmaceuticals platforms add Availability and Confidentiality; Processing Integrity and Privacy are scoped in for payments, analytics and PII-heavy products. We help you scope the right criteria to match buyer demand without over-auditing.

A SOC 2 report covers a defined period and is generally refreshed every 12 months. Buyers typically expect a report no older than a year, so Pharmaceuticals companies run a rolling annual Type II. We support the full lifecycle, including bridge letters between report dates.

Yes — and most Pharmaceuticals clients do. SOC 2 controls overlap heavily with ISO 27001 Annex A and HIPAA safeguards. Running them together reuses up to 80% of the same evidence and saves around 40% versus sequential audits.

B2B Pharmaceuticals platforms, MSPs and MSSPs, cloud service providers, software engineering firms, IT consulting and staffing groups, and data/AI platforms selling into US enterprise, healthcare or finance — where a SOC 2 report is a routine prerequisite to close.

Yes. Every ISpectra engagement includes a complimentary Vulnerability Assessment and Penetration Test. We run VAPT once the TSC technical controls are in place, so effectiveness is validated — and findings fixed — before the CPA examination.

A licensed independent CPA firm issues the SOC 2 attestation report — not ISpectra. We prepare your environment, run the internal audit and coordinate the CPA examination end-to-end, so your team stays focused on shipping product.

ISpectra handles the heavy lifting — readiness and risk assessment, 30+ policies, control rollout, free VAPT, internal audit, management review and CPA coordination. Your team provides inputs, approves deliverables and runs day-to-day operations — typically under 10% of one FTE through the sprint.

Free B2B Security Assessment

Ready to Start Your
SOC 2 Certification for Pharmaceuticals?

What you receive

Written readiness-gap report
Recommended Trust Services Criteria scope
Fixed-fee quote in 48 hours
Type I → Type II roadmap
Compliance-automation platform pick
1-hour call with a SOC 2 Lead

No obligation · Results in 48 hours · 100% confidential

Schedule a Call

Pick a time that works for you

Enable JavaScript to view the Calendly scheduler.

Open Calendly

Request Assessment

Our team responds within 24 hours

No spam. No obligations. We'll respond within 24 hours.

Encrypted & 100% confidential